Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Guohai Pharmaceutical is a specialized pharmaceutical manufacturer based in Qingdao, China, primarily focused on the production of chemical drugs and active pharmaceutical ingredients (APIs). The company is well-known for its expertise in anti-infective medications, particularly nitroimidazole derivatives such as metronidazole, tinidazole, and ornidazole. Operating under strict Good Manufacturing Practice (GMP) standards, it supplies a variety of dosage forms including tablets, capsules, and injections to the healthcare market. Beyond its core anti-infective portfolio, the company also produces cardiovascular and gastrointestinal treatments. Qingdao Guohai Pharmaceutical plays a significant role in the domestic supply chain for essential medicines while also engaging in international trade. The company emphasizes technical innovation and quality control to maintain its competitive position in the small molecule pharmaceutical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Guohai Pharmaceutical.